Dynamic Wrinkle Treatment
Muscle relaxation treatment to address dynamic wrinkles that form during expression.
Treatment Information
Duration
15-20 minutes
Body Location
Forehead, glabella, crow’s feet, masseter or selected facial muscles after assessment
Preparation
Avoid alcohol and blood thinners 24 hours before. You can do normal activities.
Follow-up Care
Mild discomfort may persist 24 hours. Do not massage face for 2 weeks.
How It Is Performed
Botulinum toxin relaxes muscles to eliminate dynamic wrinkles.
Frequently Asked Questions
Yes, static wrinkles (visible at rest) require fillers or other methods.
No, with correct dosing natural expression is preserved while reducing wrinkles.
Yes, but if permanent wrinkles develop, fillers may be needed additionally.
Pregnant, nursing, neuromuscular disease, botulinum toxin allergy, eye disease.
Injection site redness or bruising is temporary. Rare mild headache first 24 hours is normal.
Yes, can start at 25+ for wrinkle prevention. Early starters need less intensive treatment later.
No, avoid intense exercise, bending, intense massage first 24-48 hours.
Dynamic Wrinkle Treatment — Related Medical Terms
Deep-dive in our glossary: definition, indications, side effects and FAQs.
Forehead Botox
Forehead botox; It is an FDA-approved non-invasive aesthetic procedure that blocks muscle contraction and reduces dynamic lines by injecting Botulinum toxin type A into the frontal muscle (musculus frontalis) and surrounding muscles in order to treat horizontal forehead lines and wrinkles.
Crow's Feet Botox
Crow's feet botox; It is Botulinum toxin type A injection applied to the orbicularis oculi muscle to treat dynamic lines that open out from the corners of the eyes (lateral canthal lines). It is applied in a dose of 6-9 units with a standard 3-point injection pattern and reduces laughing lines for 3-6 months.
Masseter Botox
Masseter botox; It is an aesthetic and medical injection treatment used to slim the jaw shape by reducing muscle volume or to treat bruxism (teeth grinding) with Botulinum toxin type A injected into the masseter muscle located in the corner of the jaw.
microbotox
Microbotox (other names: MesoBotox, Dermal Botox) is the intradermal injection of diluted Botulinum toxin type A into the superficial dermal layer in micro-doses of 0.01-0.03 mL; It aims to improve skin quality, pore tightness, sebum production and sweat production without affecting the facial muscles.
frontalis
The frontal belly of the occipitofrontalis muscle, which pulls the forehead skin and eyebrows upward; Bilateral facial muscle, which is the primary cause of forehead lines and the main target of forehead botox.
procerus
The small pyramidal muscular structure located on the root of the nose is the facial expression muscle that pulls the eyebrows medially and creates horizontal "rabbit lines" in the glabella region; Glabellar complex is the primary target of Botox applications.
Corrugator Supercilii
The glabella muscle is the pyramidal muscle located behind the medial superciliary (above the eyebrow) of the forehead area; The main muscle that works bilaterally and pulls the eyebrows medially and downwards, forming the pionels and glabellar "11 lines"; The primary goal of Botox treatment.
Hyaluronic Acid
Hyaluronic acid (HA), the active ingredient used in dermal fillers, is a high molecular weight glucosaminoglycan polymer composed of β-1,4-D-glucuronic acid and β-1,3-N-acetyl-D-glucosamine repeating disaccharide, occurring naturally in the body; It is the most commonly used filler in facial filler in aesthetic injections, increasing skin hydration and volumetricity.
Daxxify (Daxibotulinumtoxin-A)
Daxxify; Botulinum toxin type A product, developed by Revance Therapeutics, containing a peptide stimulator (RTP-004) and approved by the FDA for cosmetic indication in 2022, used in the treatment of glabellar wrinkles; It is a longer-acting alternative to Botox, with an effect duration of up to 6 months.
Jeuveau (Prabotulinumtoxin-A)
Jeuveau; Evolus Inc. It is a botulinum toxin type A neurotoxin injection treatment, containing prabotulinumtoxin-A, produced by Daewoong Pharmaceutical (South Korea), marketed by Daewoong Pharmaceutical (South Korea), approved by the FDA in 2019 primarily for cosmetic indication (glabellar lines), has a dose equivalent to Botox, has a rapid onset of effect (2-3 days) and is positioned with an economical price.
Related Services
Plan an Assessment
Contact Dr. Hamza Gemici’s clinic for individualized assessment and candidacy planning.